Successful rechallenge with cetuximab after progression with nivolumab for recurrent cervical lymph node metastasis from carcinoma of the tongue

Clin Case Rep. 2021 Jul 16;9(7):e04464. doi: 10.1002/ccr3.4464. eCollection 2021 Jul.

Authors

Yasuyuki Asada¹, Chitoshi Teramura², Takuma Wada², Yoshisato Machida¹, Shinya Koshinuma¹, Gaku Yamamoto¹

Affiliations

¹ Department of Oral and Maxillofacial Surgery Shiga University of Medical Science Shiga Japan.
² Department of Oral and Maxillofacial Surgery Otsu City Hospital Shiga Japan.

Abstract

We can infer that the immunostimulatory effect of nivolumab and reactivation of cetuximab enhance the antitumor effect of the therapy.

Keywords: carcinoma of the tongue; cetuximab; metastasis; nivolumab; rechallenge.

© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Publication types

Case Reports